What others say…
Dr Bryan Tan, Head of Medical Affairs & Clinical Development, MDI
“Kim played a critical role as a consultant across our Phase I and III studies in the UK, Ireland, and China. Kim's expertise, insights, and tireless efforts were instrumental in the success of our clinical trials. Kim's ability to identify gaps and risks that had not been previously highlighted enabled us to rescue the studies and make strategic decisions to optimize operations and company spend. Her exceptional communication skills, cultural sensitivity, and ability to manage cross-functional teams despite language barriers were invaluable to our teams. Kim's breadth of experience in the CRO and Pharma industry was evident, and her persistent efforts in holding project team members and vendors accountable to their promises were crucial to the success of the trials. Kim’s contributions allowed us to make sound business decisions that ensured our pivotal clinical trials and pipeline continued. Kim's professionalism, expertise, and dedication to the success of the trials were evident throughout her tenure. Her impact was far-reaching and left an indelible mark on our team, vendors, and CROs. We are grateful for her contributions and highly recommend her for any future consulting engagements in the clinical trials space. Overall, Kim Steel is an exceptional consultant whose contributions went far beyond expectations. Kim is an asset to any team or organization and we look forward to the opportunity to work with her again. (June 2023)”
Tom Okarma, Executive Chairman, Regencor
“An extremely well managed CRO. We are thrilled with all aspects of the service provided by SAPRO, rapid response times to new queries, issues, expectations are exceeded and executed beautifully and accurate in detail.” (2024)
Daniel Dix, Director of Clinical Operations formerly of BioCryst Pharmaceuticals
“Kim is a top-notch leader, researcher and motivator. Kim served as a Director for the APAC region on a large, phase 3 global study I was managing. her ability to think critically to find solutions to complex problems then navigate the team to properly execute on those solutions, is uncanny. I’ve worked on several studies across various indications and Kim sticks out as one of the most dedicated and knowledgeable individuals (with a transferrable skillset) that I have worked with. I hope we can work together again sometime.”
Tom Rau, CEO a& Alyce Mayfosh, CSO of Wintermute Biomedical
“We are immensely grateful for the outstanding support provided by Kim Steel and the SAPRO team throughout our Phase Ib clinical trial at Wintermute Biomedical. Kim's exceptional communication and meticulous budgeting ensured a seamless workflow, culminating in the timely approval and budget adherence for our project. Through their efforts, we successfully received HREC approval, aligning with our timeline and setting the stage for the trial launch. SAPRO Consulting's expertise, unwavering support, and nimble problem-solving have been instrumental, and we wholeheartedly endorse them as a premier Clinical Research Organization”. (Dec 2023)
Sue Anne Yee, Director, Medical Developments International (MDI)
SAPRO was instrumental in assisting us rescue and close our study, facilitating a robust analysis and CSR that will be pivotal in the management of pain across the UK and Ireland. (Feb 2024
Aoifa Brogan, Director of Plexus
“Kim has an innate ability to effectively manage multiple, highly complex projects with enviable ease, an unrivalled work ethic, and a unique inner drive to succeed. Kim keeps her mind firmly on the end goal ensuring encountered obstacles are of little consequence. Kim is a team player with an infectious positive outlook on life. Kim comes highly recommended as an extremely valuable asset to any company.”
Linda May-Zhang, CSO of Blue California (Phyto Group)
“SAPRO was accommodating to all of our requests and kept our project going despite internal challenges, highly recommended for local sponsorship, remote monitoring and robust site management.”(2024)
Dr. Clare McAleer, Director Regulatory Affairs of Pfizer
“Kim is a consummate professional. She is driven, knowledgeable and a joy to work with. Can’t recommend Kim highly enough to those in the industry.”
Julian Abeysundera, New Zealand Operations Director, Novotech
I’ve had the opportunity to work closely with Kim over the past 6 years and seen her develop within her career. Kim is uniquely adept at resolving client issues and bringing about positive solutions. Kim’s collaborative style coupled with her therapeutic area knowledge has been an invaluable asset to my team.”